Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B.
Antoine
C
C
Sce de Néphrologie, Inserm U 430, Paris, France.
Landau
A
A
Menoyo
V
V
Duong
J P
JP
Duboust
A
A
Glotz
D
D
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D005260:Female; D006515:Hepatitis B virus / Q000302:isolation & purification; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D016030:Kidney Transplantation; D019259:Lamivudine / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012449:Safety
D000998:Antiviral Agents; D004279:DNA, Viral; D019259:Lamivudine